tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Changmao Biochemical Announces Delay in Circular Dispatch for Major Transaction

Story Highlights
Changmao Biochemical Announces Delay in Circular Dispatch for Major Transaction

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Changmao Biochemical Engineering Co. Ltd. Class H ( (HK:0954) ) has shared an update.

Changmao Biochemical Engineering Co. Ltd. announced a delay in the dispatch of a circular related to a major transaction involving a sale and leaseback arrangement. The company has received a waiver from the Stock Exchange for this delay, with a new deadline set for August 12, 2025, to dispatch the circular.

More about Changmao Biochemical Engineering Co. Ltd. Class H

Changmao Biochemical Engineering Co. Ltd. is a joint stock limited company incorporated in the People’s Republic of China. It operates in the biochemical engineering industry, focusing on the production and sale of biochemical products.

Average Trading Volume: 401,920

Technical Sentiment Signal: Sell

Current Market Cap: HK$164.2M

See more insights into 0954 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1